GE HealthCare is reported to be acquiring Sofie Biosciences for about $1,000,000,000, expanding its radioactive diagnostic agents business and strengthening its diagnostic imaging portfolio.
GE HealthCare is reported to be in advanced talks to buy Sofie Biosciences for about $1 billion, which expands its radioactive diagnostic agents business and supports GEHC's imaging offerings.
Follow GE HealthCare Technologies (GEHC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GEHC